Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative; Comment on “The Trans-Pacific Partnership: Is It Everything We Feared for Health?”

Document Type: Commentary

Authors

1 ECOHOST, Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK

2 Department of Sociology, University of Oxford, Oxford, UK

Abstract

In this commentary, we endorse concerns about the health impact of the trans-pacific partnership (TPP), paying particular attention to its mechanisms for investor state dispute settlement. We then describe the different, judgeled approach being advocated by the European Commission team negotiating the Trans-Atlantic Trade and Investment Partnership, arguing that, while not perfect, it offers significant advantages.

Keywords

Main Subjects


 "Watch the Video Summary"

 

  1. Kickbusch I. Addressing the interface of the political and commercial determinants of health. Health Promot Int. 2012;27(4):427-428. doi:10.1093/heapro/das057
  2. Mindell JS, Reynolds L, Cohen DL, McKee M. All in this together: the corporate capture of public health. BMJ. 2012;345:e8082. doi:10.1136/bmj.e8082
  3. Friel S, Hattersley L, Snowdon W, et al. Monitoring the impacts of trade agreements on food environments. Obes Rev. 2013;14 Suppl 1:120-134. doi:10.1111/obr.12081
  4. Attaran A. How do patents and economic policies affect access to essential medicines in developing countries? Health Aff (Millwood). 2004;23(3):155-166.
  5. Stuckler D, Nestle M. Big food, food systems, and global health. PLoS Med. 2012;9(6):e1001242. doi:10.1371/journal.pmed.1001242
  6. Kentikelenis A, King L, McKee M, Stuckler D. The International Monetary Fund and the Ebola outbreak. Lancet Glob Health. 2015;3(2):e69-70. doi:10.1016/s2214-109x(14)70377-8
  7. Jenkins R, Newell P. CSR, tax and development. Third World Q. 2013;34(3):378-396.
  8. Mazzucato M. The Entrepreneurial State: Debunking Public vs. Private Sector Myths. London: Anthem Press; 2015.
  9. Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med. 2012;9(6):e1001235. doi:10.1371/journal.pmed.1001235
  10. Labonté R, Schram A, Ruckert A. The trans-pacific partnership: is it everything we feared for health? Int J Health Policy Manag. 2016;5(8):487-496. doi:10.15171/ijhpm.2016.41
  11. Jarman H. Public health and the Transatlantic trade and investment partnership. Eur J Public Health. 2014;24(2):181.
  12. Bennet N. Health concerns raised over EU–US trade deal. Lancet. 2014;384(9946):843-844.
  13. Russell A, Wainwright M, Mamudu H. A Chilling Example? Uruguay, Philip Morris International, and WHO's Framework Convention on Tobacco Control. Med Anthropol Q. 2015;29(2):256-277.
  14. Côté C. Is It Chilly Out There? International Investment Agreements and Government Regulatory Autonomy. AIB Insights. 2016;16(1):14-16.
  15. Steele SL, Gilmore AB, McKee M, Stuckler D. The role of public law-based litigation in tobacco companies' strategies in high-income, FCTC ratifying countries, 2004-14. J Public Health (Oxf). 2015. doi:10.1093/pubmed/fdv068
  16. McKee M. Brexit: the NHS is far safer inside the European Union. BMJ. 2016;353:i2489. doi:10.1136/bmj.i2489